by Xcellerant Ventures | Sep 24, 2024 | Portfolio Company News, Xcellerant Ventures News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240924360690/en/Xcellerant-Ventures-Leads-DeepLook-Medical%E2%80%99s-Series-A-Round SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures is proud to announce that it will lead...
by Xcellerant Ventures | Sep 17, 2024 | Portfolio Company News
Origionally posted on DeepLook Medical’s Website: https://www.deeplookmedical.com/post/deeplook-medical-s-dl-precise-improved-the-performance-of-the-breast-imaging-department-with-12-fa Finding cancer in a mammogram is difficult, especially with women who...
by Xcellerant Ventures | Aug 12, 2024 | Portfolio Company News
Origionally posted on EIN Presswire: https://www.einpresswire.com/article/710284206/lenoss-medical-oversubscribes-4-million-series-a-financing SAN DIEGO–(BUSINESS WIRE)–CRISPR QC, a pioneering biotechnology company in San Diego, is excited to...
by Xcellerant Ventures | Jul 27, 2024 | Portfolio Company News
Origionally posted on CRISPR QC’s website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-Cleave-Case-Study-Layout.pdf Key Takeaways: CRISPR QC’s in vitro CRISPR-Cas cleavage assays can streamline CRISPR workflows by identifying optimal...
by Xcellerant Ventures | Jul 26, 2024 | Portfolio Company News
Origionally posted on CRISPR QC’s website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-RNP-Case-Study-Layout.pdf Key Takeaways: A critical gap exists in the CRISPR workflow: the lack of an in vitro QC step. The CRISPR Analytics...
by Xcellerant Ventures | Jul 25, 2024 | Portfolio Company News
Origionally posted on CRISPR QC’s website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-DNA-Case-Study-Layout.pdf Key Takeaways: The CRISPR Analytics Platform is an in vitro tool for measuring CRISPR editing efficiency, as well as, RNP...
